16 overflade, er den systemiske eskponering (dvs AUC) af tacrolimus fra Protopic cirka 30- gange mindre end hvad man finder ved orale immunosuppressive doser i nyre - og levertransplanterede patienter.
AUC) of tacrolimus from Protopic is approximately 30-fold less than that seen with oral immunosuppressive doses in kidney and liver transplant patients.